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Alzheimer Disease Susceptibility Loci:
Evidence for a Protein Network under Natural Selection
Towfique Raj,1,2,3,4 Joshua M. Shulman,1,3,4 Brendan T. Keenan,1,4 Lori B. Chibnik,1,3,4
Denis A. Evans,5,6 David A. Bennett,5,6 Barbara E. Stranger,2,3,4 and Philip L. De Jager1,3,4,*
Recent genome-wide association studies have identified a number of susceptibility loci for Alzheimer disease (AD). To understand the
functional consequences and potential interactions of the associated loci, we explored large-scale data sets interrogating the human
genome for evidence of positive natural selection. Our findings provide significant evidence for signatures of recent positive selection
acting on several haplotypes carrying AD susceptibility alleles; interestingly, the genes found in these selected haplotypes can be assem-
bled, independently, into a molecular complex via a protein-protein interaction (PPI) network approach. These results suggest a possible
coevolution of genes encoding physically-interacting proteins that underlie AD susceptibility and are coexpressed in different tissues. In
particular, PICALM, BIN1, CD2AP, and EPHA1 are interconnected through multiple interacting proteins and appear to have coordinated
evidence of selection in the same human population, suggesting that they may be involved in the execution of a shared molecular func-
tion. This observationmay be AD-specific, as the 12 loci associated with Parkinson disease do not demonstrate excess evidence of natural
selection. The context for selection is probably unrelated to AD itself; it is likely that these genes interact in another context, such as in
immune cells, where we observe cis-regulatory effects at several of the selected AD loci.Alzheimer disease (AD [MIM 104300]) is themost common
neurodegenerative disease and is a leading cause of
dementia.1 Sporadic late-onset AD has a genetic compo-
nent that includes the well-known ε4 haplotype of APOE
(MIM 107741) and other loci that harbor susceptibility
alleles.2–6 However, the functional consequences and
evolutionary history of these loci and their possible
interactions remain largely unknown. Previous studies
reporting evidence of selection at the APOE locus7,8 sug-
gested the hypothesis that AD-associated pathways may
have experienced selection in human populations, quite
possibly due to selective pressure on a phenotype un-
related to AD, given that AD has little impact on an
individual’s reproductive fitness. To further explore this
hypothesis, we integrated evidence for natural selection
within validated AD loci with a pathway-based analysis
of these loci and an examination of transcriptional
patterns in immune cells. We identified several genes in
AD susceptibility loci that appear to physically interact
and that show evidence of having undergone natural
selection. Additionally, several of these loci exhibit a cis-
regulatory effect on the transcription levels of the selected
genes in immune cells, suggesting one plausible mecha-
nism by which an AD-related molecular pathway may
have evolved in response to environmental pressures in
early human history.
Given reports that the APOE ε4 haplotype exhibits
evidence for natural selection,7,8 we assessed all validated
and well-replicated AD susceptibility loci3,4 for evidence
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genomic regions harboring genetic variants inferred to
have recently and rapidly increased in frequency within
human populations. We applied the integrated haplotype
score (iHS)9 statistic, which measures the lengths of
the haplotypes around a given SNP, to identify evidence
of positive selection in human populations of African
(Yoruba from Ibadan, Nigeria [YRI]), European (Centre
d0E´tude du Polymorphisme Humain samples from Utah
residents of European descent [CEU]), and East Asian
(Japanese subjects from Tokyo and Han Chinese sub-
jects from Beijing representing Asian populations [ASI])
ancestry from phase II of the International HapMap
Project.10 The iHS statistic was implemented with a mean
of 0 and a variance of 1. To discover signatures of selec-
tion on the haplotype bearing AD susceptibility alleles,
we searched for SNPs meeting a stringent threshold of
jiHSj > 2 (corresponding to the most extreme 5% of iHS
values across the genome among HapMap II SNPs with
minor allele frequency > 0.05) within the LD block con-
taining the index SNP of each locus from two large-scale
AD genome-wide association studies (GWAS).3,4 Further-
more, we restricted our analysis to SNPs with r2 > 0.5
and/or D0 ¼ 1, the published index SNP being associated
with AD in each locus. Although we tested only 11 loci,
we applied a stringent correction for genome-wide testing
to identify only the most robust signals of selection. Using
this approach, we found evidence for selection acting on
haplotypes carrying AD-associated alleles in 3 of 11 loci,
including PICALM (MIM 603025; rs561655), BIN1 (MIMrosciences Department of Neurology, Brigham and Women’s Hospital, 77
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Table 1. Alzheimer Disease Susceptibility Loci with Evidence of Positive Selection
Chr Index SNP Locus Tag SNPa
Integrated Haplotype Score (iHS)
ASI CEU YRI
Loci with Evidence of Selection
11q14 rs561655 PICALMb rs659023 2.17 1.31 1.88
2q14 rs7561528 BIN1b rs10200967 2.58 1.64 1.45
6p12 rs9349407 CD2APb rs9395288 2.06 0.49 1.08
11q12 rs610932 MS4A2b rs610932 0.88 0.73 1.92
Other Loci
7q35 rs11767557 EPHA1b – 0.74 0.27 0.59
1q32 rs6701713 CR1 – 0.11 0.26 0.71
19q13 rs3865444 CD33 – 0.43 0.87 –
19q13 rs2075650 APOE – 0.55 1.5 –
19q13 rs4420638 APOE – 0.45 0.7 0.16
8p21 rs1532278 CLU – – – –
19p13 rs3764650 ABCA7 – – – –
ASI, East Asian; YRI, African; CEU, European.
aTag SNPs: SNPs that best capture the selection signal on each AD susceptibility haplotype. Tag SNPs were chosen on the basis of their LD (r2 > 0.5; D0 ¼ 1) with
the published index SNP for each locus, evidence for selection signals, and AD GWAS association at p< 106. Absolute iHS> 2 and> 1.65 correspond to the most
extreme 5% and 10% of iHS values across the genome, respectively.
bShows evidence for selection in gene-based analyses (Table S2).601248; rs7561528), and CD2AP (MIM 604241;
rs9349407) (Table 1). All of these loci showed significant
(with the use of a threshold for genome-wide testing)
evidence for selection in the same HapMap population of
East Asian descent, suggesting that the loci may have
responded to the same selective pressure. Using a less
stringent ‘‘suggestive’’ threshold of significance (jiHSj >
1.65, corresponding to the top 10% of iHS values across
the genome), we also saw evidence of natural selection at
MS4A2 (MIM 147138; rs610932) in the African population
(Table 1). Except for the MS4A2 locus, the index SNP from
the reported AD GWAS was not the SNP exhibiting the
strongest evidence of selection. This is not surprising given
that these index SNPs emerged from genome-wide screens
and are most likely surrogate markers for the causal
variant(s) in each locus. The evidence for selection may,
in fact, help to pinpoint variants that are more likely to
have a functional effect involved in driving the selection
process and perhaps AD susceptibility.
Interestingly, each positively selected allele on the
AD-associated haplotypes in the PICALM, BIN1, and
CD2AP loci had a high positive iHS score in the East Asian
subjects (Table 1). A positive iHS means that the haplo-
types with the ancestral allele that humans share with
chimpanzees are longer than those containing the derived
allele; therefore, these results suggest that selection favored
the ancestral allele at all three loci. Although a neighboring
derived allele that is targeted by a selective force could
drive selection at one ancestral allele, this is unlikely to
be the case in all three loci. It is more likely that the threeThe Amancestral alleles are themselves the targets of selection. In
all three cases, the selected ancestral alleles are those asso-
ciated with diminished susceptibility to AD; the derived
alleles are the risk alleles. This observation introduces the
possibility that these three loci worked together in a shared
pathway and were affected in a coordinated manner over
the course of human evolution in the East Asian popula-
tion that encountered a specific selective pressure. Further-
more, the three risk-associated alleles have all been selected
against, suggesting that they may have converging effects
on the same cellular function, one implicated in AD
susceptibility but most likely important in other contexts
as well.
To further confirm the robustness of the selection
signals, we deployed alternative methods of selecting
SNP sets with which to detect evidence for natural
selection in AD loci and validate the results of the haplo-
type-based iHS analysis. In a region-based analysis, we
determined the proportion of SNPs with jiHSj > 2 in
a 50-SNP window centered on the index SNP. In a gene-
based approach, we created a window of 50 SNPs centered
on each gene closest to the index SNP; the genes in the
upper 10% of the empirical distribution for number of
significant SNPs were then considered to be candidate
targets of selection (Table 2). Table 2 and Table S1 summa-
rize the results of these analyses; they are consistent with
the results of the haplotype-based analysis. In these ana-
lyses, we subsequently explored the possibility that APOE
or genes associated with early-onset, Mendelian forms
of AD (APP [MIM 104760], PSEN1 [MIM 104311], anderican Journal of Human Genetics 90, 720–726, April 6, 2012 721
Table 2. Alzheimer-Disease-Associated Haplotypes, Regions, and Genes with Evidence of Positive Selection
Locus SNP Gene
Three Different Approaches to Assess for Evidence of Positive Selection
Haplotype Region Gene
ASI CEU YRI ASI CEU YRI ASI CEU YRI
6p12 rs9349407 CD2AP þ þ þ
11q12 rs610932 MS4A2 þ þ þ
11q14 rs561655 PICALM þ þ þ þ þ
2q14 rs7561528 BIN1 þ þ þ
7q35 rs11767557 EPHA1 þ
Evidence of selection (indicated by ‘‘þ’’) based on the analyses from alternate methods of selecting SNP sets with which to evaluate evidence for selection.
The ‘‘haplotype’’ analysis is our primary analysis. In the haplotype analysis, we searched for SNPs in LD (r2> 0.5; D0 ¼ 1) with the index SNP in each locus (Table 1).
We then considered haplotype blocks containing a linked SNP with jiHSj> 2 to be candidate targets of selection. We deployed secondary analyses to illustrate the
robustness of our results. For our secondary regional analysis, we determined the number of SNPs with jiHSj> 2 in a 50-SNP window centered on the GWAS SNP.
We then considered the regions in the upper 10% of the empirical distribution for proportion of SNPs with jiHSj> 2 to be candidate targets of selection. For gene-
based analysis, we determined the proportion of SNPs with jiHSj> 2 in a 50-SNP window centered on the gene closest to the GWAS SNP. We then considered the
genes in the upper 10% of the empirical distribution for number of significant SNPs to be candidate targets of selection. The symbol ‘‘þ’’ indicates evidence for
selection at each locus in three HapMap populations.PSEN2 [MIM 600759]) harbor evidence of natural selec-
tion; however, none of these loci returned jiHSj scores
that met our suggestive or significant thresholds (data
not shown).
To test for enrichment of positive selection among the
AD-associated loci, we compared the proportion of haplo-
types with positively selected loci in the set of AD-
validated loci with a similar list of Parkinson disease (PD
[MIM 168600]) -validated loci (n ¼ 12).11 In this targeted
analysis, we imposed our suggestive jiHSj > 1.65 threshold
and found that the proportion of AD-associated loci
meeting this threshold of evidence for selection in at least
one HapMap population (45%, 5 of 11 SNPs have jiHSj >
1.65; Table 1) was higher than the proportion of PD
loci under selection (8%, 1 of 12 SNPs have jiHSj > 1.65;
c2AD versus PD ¼ 4.774, pAD versus PD ¼ 0.029). These results
suggest enrichment for loci with evidence of selection
amongvalidatedAD susceptibility loci.Weobtained similar
results when comparing the AD loci to random sets of SNPs
with similar allele frequencies (data not shown).
On the basis of the hypothesis that evidence for natural
selection might be a feature of other, as-yet undiscovered
AD susceptibility loci, we extended these analyses to the
list of loci that met a suggestive threshold of significance
(p< 104) for association with AD susceptibility in a recent
GWAS that provided a comprehensive list of such results.3
Out of an initial 447 suggestive SNPs in this study, we
found 118 loci with independent effects (after LD pruning
of SNPs with an r2¼ 0.5 threshold). We found that 10 (8%)
of these 118 loci have an jiHSj > 2 and therefore meet our
threshold of genome-wide significance. Furthermore, 21
loci (18%) demonstrate suggestive evidence (jiHSj > 1.65)
of natural selection, which is more than expected by
chance (expected: 11.8 [10%]; p ¼ 0.005). Thus, our obser-
vation in the validated AD loci may be a more general
feature of AD susceptibility loci.
Given that 3 of 11 AD-associated loci show evidence of
selection in the same human population, it is plausible722 The American Journal of Human Genetics 90, 720–726, April 6, 2that some of the genes they contain may have a correlated
evolutionary history and are coevolving. Coevolution can
occur when a heritable change in one gene establishes
selective pressure for another gene.12 To detect such coevo-
lutionary processes, we constructed protein-protein inter-
action (PPI) networks to identify interacting proteins,
because two proteins are more likely to share correlated
evolutionary history if they physically interact.13 This
method of constructing networks does not leverage infor-
mation regarding natural selection and is therefore inde-
pendent of our earlier analyses. To construct a PPI network,
we selected genes found within validated and sug-
gested AD-associated loci (defined as the genomic segment
bounded by SNPs with an r2 > 0.5 to the index SNP for
a given locus) as input for the web-based tool Disease
Association Protein-Protein Link Evaluator (DAPPLE),
which uses high-confidence pairwise protein interactions
and tissue-specific expression data to reconstruct a PPI
network.14 The network is conservative, requiring that
interacting proteins be known to be coexpressed in a given
tissue. The resultant AD PPI network returned by DAPPLE
is statistically significant for a network connectivity that
allows a common interactor protein (not known to be asso-
ciated with AD) between AD genes when compared to
1,000 random networks (permuted p ¼ 0.043; Figure 1).
This analysis is not significant (p ¼ 0.367) when direct
network connectivity between the AD genes is required.
We were able to indirectly connect all but two of the
proteins coded in known AD loci (ABCA7 [MIM 605414]
and CR1 [MIM 120620]).
When overlaying our AD PPI network allowing for
a common interactor protein with the results of our
analyses for evidence of natural selection, an intrigu-
ing subnetwork that includes the proteins encoded by
PICALM, BIN1, CD2AP, and EPHA1 (MIM 179610)
emerged. Integrating our gene-based PPI results with our
gene-based selection analysis (Table S1), we saw that all
four susceptibility loci showed evidence of positive012
Figure 1. Protein-Protein Interaction Network
Generated from Proteins Encoding for AD-
Associated and -Suggested Genes
The 118 LD-pruned SNPs (p < 10-4) from the Alz-
heimer Disease Genetics Consortium (ADGC)
GWAS3, which provided a complete list of sugges-
tive results, were included as an input to DAPPLE.
DAPPLE selects genes from a SNP list based on the
region containing SNPs with an r2 > 0.5 to each
index SNP; this region is then extended to the
nearest recombination hot spot. AD-associated
proteins are represented as nodes connected by
an edge if there is in vitro evidence for high-confi-
dence interaction. The large colored circles repre-
sent AD-associated and -suggestive proteins, and
small circles in grey represent the connected
proteins (not known to be associated with AD).
Most of the AD-associated proteins are connected
via common interactor proteins (gray) with
which the associated proteins each share an
edge. The red points indicate genes (CD2AP,
PICALM, BIN1, EPHA1, and MS4A2) under posi-
tive selection in our gene-based analyses of
HapMap II populations (Table S1). The PPI
network is statistically significant for indirect
connectivity (PPI network permuted p ¼ 0.043).selection in East Asians (Table 2 and Table S1). This
evidence suggests a possible coevolution of these four
genes, which, on the basis of the PPI analysis, may interact
in a macromolecular complex (Figures 1 and 2). To assess
the statistical significance of this subnetwork, we con-
structed a new PPI network by using these four genes as
the seed regions, and found that the subnetwork was statis-
tically significant for indirect connectivity (permuted p ¼
0.033; Figure 2). We observed that many of the interacting
proteins connecting the AD-associated proteins also
showed significant evidence for selection (Figure 2), and,
interestingly, one of these proteins is encoded by a gene
(GAB2 [MIM 606203]) that has been previously suggested
to be associated with AD.15,16 Thus, these AD-associated
and ‘‘connector’’ genes may have been under selection
because of their participation in a single functional module
over evolutionary time, and common function may also
explain their individual associations with AD suscepti-
bility. Given the late age-at-onset of AD, it is unlikely
that this phenotype itself has been the target of selec-
tion over evolutionary time; rather, it is likely that these
four genes, along with their interaction partners, com-
pose a functional module that is important in other biolog-
ical contexts.
Some of the strongest selective pressures acting during
human evolution have been attributed to human interac-
tions with pathogens; we thus investigated the functional
consequences of AD-associated variants with evidence of
selection on gene expression levels in immune cells. This
approach was additionally motivated by the observationThe American Journal ofthat some AD-associated variants map close
to genes with putative immune function
(i.e., CD33 [MIM 159590], CR1, andMS4A2) and others, such as PICALM, BIN1, CD2AP, and
EPHA1, are coexpressed in immune cells, particularly in
the myeloid lineage.17 Thus, we assessed each of the 11
validated and well-replicated AD loci for evidence of an
effect on RNA expression in cis; that is, we performed an
expression quantitative trait locus (eQTL) analysis in
each locus for genes in the vicinity of the index SNP (see
Supplemental Material andMethods). We first investigated
genetic variation and mRNA expression in an available
data set derived from peripheral blood mononuclear cells
(PBMCs) of 228 individuals of European ancestry with
demyelinating disease,18 representing a set of subjects
with an activated immune system. PBMCs are purified
from peripheral blood and contain both myeloid and
lymphoid cells. After gene-based permutation assessing
significance of SNP-gene association p values, we identified
five cis-regulatory effects in the 11 tested loci (Table S2).
Specifically, we found three AD-associated index vari-
ants—rs610932, rs7561528, and rs3752246—with cis-
regulatory effects in PBMCs: rs610932 influences the
expression of neighboring MS4A2 (nominal p ¼ 5.04 3
108), whereas rs7561528 and rs3752246 affect the ex-
pression of BIN1 (p ¼ 4.76 3 104) and ABCA7 (p ¼
6.87 3 105), respectively. These cis-regulatory effects are
all significant at a p < 0.05 permutation threshold; the
same MS4A2 and BIN1 haplotypes harbor evidence of
natural selection (Table 1).
In the PICALM locus, which has strong evidence of selec-
tion, the current best ADmarker does not have a strong cis-
regulatory effect on gene expression, but other SNPs thatHuman Genetics 90, 720–726, April 6, 2012 723
Figure 2. Protein-Protein Interaction Subnet-
work of AD-Associated Genes under Positive
Selection
The subnetwork is simply a highly intercon-
nected subset of the larger network that emerges
from DAPPLE and is illustrated in Figure 1.
The subnetwork is statistically significant for
indirect connectivity (PPI subnetwork permuted
p¼ 0.033). As in Figure 1, the red dotsmark genes
with evidence for natural selection.have evidence of association with AD (p < 5x108 in pub-
lished studies) 3,4 and are in strong LD with the index SNP
have replicated evidence of having a cis-regulatory effect
on gene expression. Specifically, the AD risk allele
rs659023G (pAD ¼ 2.78 3 1010)3 (r2 ¼ 0.8 with index
PICALM SNP rs561655) is significantly associated with
decreased expression of PICALM in PBMC (p ¼ 4.76 3
104; Figure S1). We replicate this cis-regulatory effect in
CD4þ T lymphocytes (which are constituents of the
PBMC cell mixture) of 40 healthy individuals of European
ancestry (p ¼ 2.48 3 104).
In the case of PICALM, the evidence for selection and the
effect on gene expression converge (Figure 3; Table S3): the
rs659023 SNP discussed above exhibits a strong correlation
with PICALM RNA expression and has a high iHS (eQTL
p ¼ 4.76 3 104, jiHSj ¼ 2.17). These results suggest that
one or more potential functional variants that influence
PICALM expression may have been selected for over the
course of human history in this well-validated AD locus.
This information can be leveraged to focus fine-mapping
efforts onto a short list of candidate causal variants that
can be targeted in well-powered AD susceptibility analyses.
In summary, we observe significant evidence for signa-
tures of positive selection on haplotypes associated with
late-onset Alzheimer disease. The most intriguing finding
of our study is that multiple AD-associated genes (i.e.,
PICALM, BIN1, CD2AP, and EPHA1) with evidence for posi-
tive selection encode proteins that physically interact
within an independently defined PPI network. Further-
more, some of the linking proteins in the network also724 The American Journal of Human Genetics 90, 720–726, April 6, 2012show evidence of positive selection, and
one of these,GAB2, has previously been sug-
gested to be associated with AD.15,16 The
convergence of results in these two comple-
mentary analyses suggests that these four
interacting proteins encoding for AD
susceptibility genes may have had a corre-
lated evolutionary history, perhaps in
response to a single evolutionary pressure
that affected East Asian populations and,
to a lesser degree, European populations
(Table 2). Moreover, we found that several
of these loci exhibit a cis-regulatory effect
on the transcription of the selected genes
in immune cells, suggesting that changes
in gene expression may be one mechanismbywhich anAD-relatedmolecular pathway evolved in early
human history, most likely in a non-AD context.
The resultspresentedhereprovide convincing support for
recent positive selection of loci underlying late-onset AD,
but what are the selective pressures underlying the signa-
tures? It is difficult to identify the precise selective pressure
that led to our observations. Selection may result from an
array of forces including pathogen resistance aswell as envi-
ronmental and dietary changes as modern humans
migrated out of Africa and spread throughout the world.
For thegeneswithputative immune functions,we speculate
that pathogens may have exerted selective pressures on
populations and consequently influenced the frequency
of AD-associated alleles. Regardless of what the selection
pressure might have been, our results suggest that several
different loci implicated in AD susceptibility may have
worked together in another context to enhance survival
over the course of recent human evolutionary history.
Evidence for natural selection at a given variant suggests
that such a variant may have functional consequences,
given that the selection process was mediated by an alter-
ation of a biological process. One can think of selective pres-
sures asnatural, invivohumanexperiments inwhichwecan
measure the response of human populations to unknown
perturbations, and these alterations can inform the function
of geneswithin a given locus.However, by itself, evidence of
selection is not sufficient for identifying causal variants in
susceptibility loci. Rather, it offers another key dimension
of functional information to integrative analyses that
include disease association, protein-protein interaction,
Figure 3. Colocalization of cis-Regulatory Effects and Positive Selection Signals in the PICALM Locus
The top panel reports the cis-regulatory effects of each SNP in the vicinity of the PICALM locus on PICALM RNA expression in PBMC; -log
(p value) is reported on the y axis. The lower panel reports the evidence for positive selection at each SNP over the same chromosomal
segment (1 Mb total); here we have inverted the y axis so that the most extreme iHS values are at the bottom of the scale. The RefSeq
genes in the region are shown at the bottom of the figure. The LD (in r2) for each SNP with the index AD-associated PICALM SNP
(rs561655) is illustrated with the use of colors, as indicated in the top right of the figure. The haplotype carrying GWAS index SNP
rs561655 also contains other alleles that have the strongest selection signals and cis eQTL effects, suggesting that functional variants
influencing the expression of PICALM may have been the target of recent natural selection. The SNPs with extreme iHS values are
the same SNPs that have extreme p values in the cis eQTL analysis (Table S3).and gene expression. Such analyses will powerfully
explore the molecular mechanisms underlying associations
between genetic variation and disease susceptibility. In the
case of AD, we have highlighted a network of coexpressed,
physically interacting susceptibility genes that is supported
by evidence of selection; this observation lays the ground-
work for future hypothesis-driven investigations into the
function of the interactions of these susceptibility genes,
which may be related to vesicular trafficking, given the
known functions of PICALM, BIN1, CD2AP, and EPHA1.
On the basis of our expression data, characterization of cell
populations fromperipheral bloodmayprovidea reasonable
substrate for functional investigations that seek to interro-
gate the coordinated functional consequences of these four
susceptibility loci, and perhaps others.Supplemental Data
Supplemental Data include one figure and three tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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